Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 7/20 | 0.71 |
| ▸ | ESR1 | P03372 | 4/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.57 |
| ▸ | ERAP1 | Q9NZ08 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.57 |
| ▸ | GLA | P06280 | 5/20 | 0.57 |
| ▸ | GAA | P10253 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | CASP1 | P29466 | 3/20 | 0.57 |
| ▸ | CASP7 | P55210 | 3/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
| ▸ | PDE2A | O00408 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | CCR4 | P51679 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27872231 | 0.88 | HSD17B3 (0.71) | HSD17B3ESR1ESR2ERAP1KDM4E | |
| SCHEMBL2226810 | 0.88 | HSD17B3 (0.71) | HSD17B3ESR1ESR2ERAP1KDM4E | |
| SCHEMBL31281312 | 0.86 | HSD17B3 (0.69) | HSD17B3ESR1ESR2ERAP1KDM4E | |
| SCHEMBL10849966 | 0.84 | HSD17B3 (0.65) | HSD17B3ESR1ESR2ERAP1KDM4E | |
| SCHEMBL591899 | 0.83 | HSD17B3 (1.00) | HSD17B3ESR1ESR2ERAP1KDM4E | |
| SCHEMBL31366988 | 0.83 | HSD17B3 (1.00) | HSD17B3ESR1ESR2ERAP1KDM4E | |
| SCHEMBL7944663 | 0.83 | SRC (0.53) | HSD17B3KDM4EGLAGAAALDH1A1 | |
| SCHEMBL28096263 | 0.82 | HSD17B3 (0.63) | HSD17B3ESR1ESR2ERAP1KDM4E | |
| SCHEMBL14916149 | 0.82 | HSD17B3 (0.67) | HSD17B3ESR1ESR2ERAP1KDM4E | |
| SCHEMBL28446883 | 0.82 | HSD17B3 (0.96) | HSD17B3ESR1ESR2ERAP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1533 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3164196-B1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TOPGENIX INC (US) | 2021-08-18 | — | — | EP | claimed |
| EP-3164196-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TOPGENIX, INC. (US) | 2017-05-10 | — | — | EP | claimed |
| US-20170119641-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TopGeniX, Inc. | 2017-05-04 | — | — | US | claimed |
| WO-2015195546-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | TopGeniX, Inc. (US) | 2015-12-23 | — | — | WO | claimed |
| EP-2916814-A1 | COMPOSITION CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN | Colabs International Corporation (US) | 2015-09-16 | — | — | EP | claimed |
| WO-2014074555-A1 | COMPOSITION CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN | CoLabs International Corporation (US) | 2014-05-15 | — | — | WO | claimed |
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | CoLabs International Corporation (US) | 2014-05-08 | — | — | US | claimed |
| EP-2367852-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | Sederma (FR) | 2011-09-28 | — | — | EP | claimed |
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | AVICENA GROUP, INC. (US) | 2011-01-13 | — | — | US | claimed |
| WO-2010067327-A1 | COSMETIC COMPOSITION CONTAINING ACETYLATED OLIGOGLUCURONANS | SEDERMA (FR) | 2010-06-17 | — | — | WO | claimed |
| WO-2010044076-A2 | COSMETIC AND TOPICAL USE OF XANTHOHUMOL INCLUDING BRIGHTENING SKIN COMPLEXION AND REDUCING CUTANEOUS REDNESS | SEDERMA (FR) | 2010-04-22 | — | — | WO | claimed |
| EP-1924254-A2 | USE OF TELLURIUM COMPOUNDS FOR PROTECTION FROM ULTRA-VIOLET RADIATION | Biomas Ltd. (IL) | 2008-05-28 | — | — | EP | claimed |
| WO-2007032010-A2 | USE OF TELLURIUM COMPOUNDS FOR PROTECTION FROM ULTRA-VIOLET RADIATION | BIOMAS LTD. (IL) | 2007-03-22 | — | — | WO | claimed |
| US-7186416-B2 | Foamable pharmaceutical compositions and methods for treating a disorder | STIEFEL LABORATORIES, INC. (US) | 2007-03-06 | — | — | US | claimed |
| US-20060193789-A1 | Surfacant, film forming agent, water, gas propellant; plant and animal extracts and oils; may include malathion | FOAMIX LTD. (IL) | 2006-08-31 | — | — | US | claimed |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | AVICENA GROUP, INC. (US) | 2005-08-25 | — | — | US | claimed |
| US-11957769-B2 | Polyhydroxy fullerene sunscreen active agents and compositions | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-04-16 | — | — | US | disclosed |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | COLABS INT'L CORP. (US) | 2024-03-28 | — | — | US | disclosed |
| EP-0313305-A2 | Photoprotection compositions comprising chelating agents | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-26 | — | — | EP | disclosed |
| US-4098881-A | COMPOSITIONS TO CONTROL THE CHRONIC EFFECTS OF EXPOSURE TO SUNLIGHT COMPRISING CONJUGATED DIENES | THE PROCTER & GAMBLE COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110008272-A1 | Use of Creatine or Creatine Compounds for Skin Preservation | PC, CKMT1A; CKMT1B, CHEK1 | HSD17B3 1022/4885ESR1 3636/4885ESR2 3066/4885 |
| US-20140127275-A1 | Composition Containing a Cellulose Derived Capsule With A Sunscreen | MSH6, TYR, CUTA | HSD17B3 1075/4885ESR1 4690/4885ESR2 4697/4885 |
| US-20170119641-A1 | TOPICAL FORMULATIONS FOR UV PROTECTION | ERCC4, ERCC1, UNG | HSD17B3 2782/4885ESR1 4465/4885ESR2 3139/4885 |
| US-20050186158-A1 | Use of creatine or creatine compounds for skin preservation | PC, CKMT1A; CKMT1B, CHEK1 | HSD17B3 1022/4885ESR1 3636/4885ESR2 3066/4885 |
| US-20240099948-A1 | Compositions Comprising Silicon Dioxide-Based Particles Including One or More Agents | MSN, LIPE, CUTA | HSD17B3 3100/4885ESR1 4102/4885ESR2 4828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.